Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy
PharmaMar
PharmaMar
Novartis
Vanquish Oncology, Inc.
Eli Lilly and Company
Mateon Therapeutics
Novartis
INSYS Therapeutics Inc
Novartis